Home » All » Stock Forecast » INmune Bio Inc. Common stock Forecast

INmune Bio Inc. Common stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -8.05%Market Cap $36.42M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$1.40 ▲ +2.03%	Yesterday	$1.36 ▼ -0.85%	Tomorrow's INmune Bio Inc. Common stock (INMB) setup is anchored to $1.37 and targets $1.40 (+2.03%). The near-term read is upside; watch $1.41 / $1.33 because daily realized volatility is about 8.00%.
Tomorrow's INmune Bio Inc. Common stock (INMB) setup is anchored to $1.37 and targets $1.40 (+2.03%). The near-term read is upside; watch $1.41 / $1.33 because daily realized volatility is about 8.00%.
Week	$1.46 ▲ +6.31%	Last Week	$1.33 ▼ -2.65%	The 7-day INmune Bio Inc. Common stock model moves from $1.33 to $1.46 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.41 / $1.33 matter more than a single tick.
The 7-day INmune Bio Inc. Common stock model moves from $1.33 to $1.46 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.41 / $1.33 matter more than a single tick.
Month	$1.55 ▲ +13.45%	Last Month	$1.29 ▼ -5.65%	The 1-month INmune Bio Inc. Common stock target is $1.55 (+13.45%), compared with the live reference near $1.37. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month INmune Bio Inc. Common stock target is $1.55 (+13.45%), compared with the live reference near $1.37. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$1.70 ▲ +24.14%	Last Year	$1.23 ▼ -10.14%	The 1-year INmune Bio Inc. Common stock scenario points to $1.70 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year INmune Bio Inc. Common stock scenario points to $1.70 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$2.04 ▲ +49.20%	5 Years Ago	$1.09 ▼ -20.66%	The 5-year INmune Bio Inc. Common stock view is $2.04 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year INmune Bio Inc. Common stock view is $2.04 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$1.40▲ +2.03%

Yesterday$1.36▼ -0.85%

Tomorrow's INmune Bio Inc. Common stock (INMB) setup is anchored to $1.37 and targets $1.40 (+2.03%). The near-term read is upside; watch $1.41 / $1.33 because daily realized volatility is about 8.00%.

Week$1.46▲ +6.31%

Last Week$1.33▼ -2.65%

The 7-day INmune Bio Inc. Common stock model moves from $1.33 to $1.46 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.41 / $1.33 matter more than a single tick.

Month$1.55▲ +13.45%

Last Month$1.29▼ -5.65%

The 1-month INmune Bio Inc. Common stock target is $1.55 (+13.45%), compared with the live reference near $1.37. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$1.70▲ +24.14%

Last Year$1.23▼ -10.14%

The 1-year INmune Bio Inc. Common stock scenario points to $1.70 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$2.04▲ +49.20%

5 Years Ago$1.09▼ -20.66%

The 5-year INmune Bio Inc. Common stock view is $2.04 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$1.37	Mid
Daily Change	-8.05%	Below
Volatility Cap	20.0%	Mid
Confidence	75%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$1.37

Daily Change-8.05%

Market Cap$36.42M

Sourcenasdaq-screener

Current	$1.37	Daily Change	-8.05%
Market Cap	$36.42M	Source	nasdaq-screener

Support & Resistance Levels

$1.33Support 1

$1.37Current

$1.41Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$1.37Live reference price

Used as the anchor for generated forecast calculations.

Next Month$1.55Model projection+13.45%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

75%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

75%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in INMB today

Bullish Scenario

$1.44

+5.00% from current

Target Price$1.44

ScenarioUpside momentum

Probability62%

Base Scenario

$1.55

+13.45%

Target Price$1.55

ScenarioCapped drift

Probability70%

Bearish Scenario

$1.30

-5.00% from current

Target Price$1.30

ScenarioVolatility drawdown

Probability25%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 79/100

24H drift+2.03%

7D drift+6.31%

30D drift+13.45%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 75/100

1M outlook+13.45%

1Y outlook+24.14%

5Y outlook+49.20%

Frequently Asked Questions

Q What is the INmune Bio Inc. Common stock (INMB) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), INmune Bio Inc. Common stock is projected near $1.40 versus the current reference around $1.37. That implies a modeled move of +2.03% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for INMB?

The weekly INmune Bio Inc. Common stock model points to $1.46, which maps to an expected drift of +6.31% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the INmune Bio Inc. Common stock 1-month and 1-year targets?

The INmune Bio Inc. Common stock 1-month target is $1.55 (+13.45%), while the 1-year target is $1.70 (+24.14%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the INmune Bio Inc. Common stock 5-year scenario differ from short-term rows?

The INmune Bio Inc. Common stock long-horizon scenario sits near $2.04 with a modeled change of +49.20%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are INMB support and resistance zones right now?

For INmune Bio Inc. Common stock, nearest resistance is around $1.33, while nearest support is around $1.41. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the INmune Bio Inc. Common stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.